Clinical Trial Update: Phase II Study of Gemcitabine Versus S-1 Adjuvant Therapy After Hemihepatectomy for Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase II randomized trial comparing gemcitabine to S-1 as adjuvant therapy after hemihepatectomy for biliary tract cancer; the study has completed enrollment an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Biliary Tract Cancer | Phase 2 | Status: COMPLETED